| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.001 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.1 | 0.06 |